Announced
Completed
Financials
Tags
Pharmaceuticals
Private
specialty pharmaceuticals
Acquisition
Majority
Single Bidder
Private Equity
United Kingdom
Cross Border
Friendly
Completed
Synopsis
Nordic Capital, a private equity investor, completed the acquisition of ADVANZ PHARMA, a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, for $2bn. "This deal is fantastic news for ADVANZ PHARMA and our goal of becoming the go-to partner for complex medicines in Europe. Nordic Capital will be pivotal in helping the business through both its deep sector expertise and access to capital that will enable considerable investment in our organic and inorganic pipeline. This partnership will be essential in allowing us to further broaden choice for both prescribers and patients throughout the world and ensure access to the essential medicines we supply," Graeme Duncan, ADVANZ PHARMA CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.